CROI 2019 Abstract eBook

Abstract eBook

Keyword Index

• Reconstitution inflammatory syndrome (IRIS) 216, 448, 727, 728 • Recovery 203, 242, 503 • Regulation 244

Kaposi sarcoma-associated herpesvirus 17, 20, 272, 273 Kenya 94, 146, 278, 724, 824, 840, 852, 892, 896, 924, 945, 980, 1018, 1076 Key populations 840, 896, 910, 939, 959, 975, 976, 996, 1088 KICS 268 Kidney function 735, 960 Kidney transplantation 226 Knowledge 978 KSHV 18, 268, 269, 270 KwaZulu Natal 531 Kynurenine 602 Kynurenine-to-tryptophan (KT) ratio 35 Lactoferrin 231 LAg-Avidity EIA 836, 938 Lamivudine 478, 630 LASER ART 353 Late presentation 495, 627 Latency 18, 334, 336, 349, 361, 368, 372, 373, 374, 378, 379, 388 Latency model 379 Latency reversing agents 22, 26, 132, 328, 329, 352, 369, 371, 372, 373, 386, 390, 401 Latent class analysis 908 Latent HIV-1 reservoir 27, 339, 340, 342, 376, 377, 380, 385, 386, 387 Latent tuberculosis 715, 716 Latin America 274, 936, 975, 976

1086, 1087, 1091 Maturation 539

Maturation inhibitor 142, 541 Medical male circumcision 951 Medication adherence 957 Melting curve analysis 741 Memory cells 255

• Response 270, 272, 510, 620 • Restoration 571, 624, 804 • Senescence 255, 257, 271

Immunologic 504 Immunological non-responders 206, 325

Men who have sex with men (MSM) 48, 49, 104, 229, 273, 465, 524, 529, 576, 594, 596, 597, 598, 661, 834, 841, 843, 845, 846, 884, 885, 902, 912, 920, 930, 933, 934, 935, 936, 937, 939, 945, 955, 957, 966, 967, 968, 971, 972, 973, 974, 977, 990, 991, 1011, 1035, 1038, 1069, 1089 Menopause 1001 Mental health 697, 767, 819, 917, 919, 1040 Metabolic 679, 681 Metabolic complications 678 Metabolic disease 616, 655, 684, 685 Metabolic syndrome 699 Metabolism 271, 385 Metabolomics 216, 228, 267, 423 Metformin 301, 302 Methamphetamine 884, 885 Mexico 876, 877 Micro-elimination 574, 597 Microarray 312 Microbial translocation 201, 202, 303, 410, 814 Microbiome 202, 229, 230, 231, 233, 234, 236, 239, 240, 507, 520, 602, 787, 788, 998, 1001 Microbiota 206, 230, 238, 239, 242, 276, 1000 Microfluidic 330 Microglia 433

Immunomodulation 131 Immunophenotype 658 Immunosenescence 257 Immunotherapy 136, 137, 145, 302, 354, 359, 400 Impact evaluation 99, 722, 768 Implant 51, 487 Implementation science 768, 1018, 1082 In utero drug exposure 430 In vitro 183, 376, 545 In vivo 377 Inappropriate drugs 466 Incarceration 581 Incidence 85, 98, 275, 289, 599, 601, 853, 865, 941, 942, 952, 1043

Incidence assay 601, 941, 942, 943 Incidence rates 275, 289, 986, 1085 Incident infection 775 Incident tuberculosis 733, 734 Index testing 93, 783, 929, 930 Inducible reservoir 368, 803 Infant dose 757 Infants 41, 752, 801, 802 Infected cell binding 358 Infectious HIV-1 recombinants 484 Inflammatory biomarkers 35, 455, 634 Inflammatory cytokine/chemokine 280 Inflammatory monocytes 444 Influenza vaccination 319 Influenza vaccine 308 inhA mutation 82 Inhibitory receptor 254 Injectable 139 Injection drug use 893, 953 Injection equipment sharing 887 Injury 704 Innate immune response 43, 185 Innate immunity 171

LDL-cholesterol 650 Lectin binding 386 Ledipasvir/sofosbuvir 87 LEEP 14 Legacy Effect 413 Length of stay 899

Microparticles 653, 654 MicroRNA 654, 653, 683 Microvesicles 653 Migrant 284 Migration 315 Mitochondria 218, 701, 702 Mitochondrial toxicity 789 MK-8591 481 Mobility 765, 873

Infectivity 176, 190 Inflammaging 633 Inflammation 36, 201, 205, 235, 237, 243, 365, 567, 647, 657, 658, 685, 823

Linkage and retention 513, 1024 Linkage to care 892, 954, 1024, 1027 Linkage to care and treatment 927, 1029, 1051 Lipid 649

Lipid profile 326, 651 Lipidomics 326, 647 Lipids 326, 652 Lipodystrophy 683 Live-Imaging 72, 221 Liver

Modeling 467, 776, 833, 1076, 1077, 1085 Molecular epidemiology 273, 533, 856, 860 Monitoring 404 Monoclonal antibody 45, 296, 485, 486 Monocytes 245, 302, 357, 409 Morbidity 787

• Disease 606, 608, 610, 617 • Enzyme elevation 609, 616 • Fibrosis 571, 602 Long-acting 139, 140, 480, 485, 488, 489, 1076 Long-term ART 483, 763, 805, 901 Longitudinal study 183, 307, 382, 408, 794 Lopinavir 756 Loss of virological control 261

Mortality 30, 83, 138, 146, 147, 148, 274, 425, 510, 603, 663, 736, 738, 790, 880, 883, 894, 900, 901, 913, 914, 911, 1030, 1070 Mortality cause 881, 915 Mortality rates 915 Mother-to-child transmission 166, 306, 758, 761, 773, 776,

Insulin resistance 679, 814 Intact HIV-1 DNA 383, 806 Integrase 73, 74, 528, 557

Loss to follow-up 148, 908, 1030, 1032 Low- and middle-income countries 518 Low-level viremia 97, 348, 497, 517 LTR 74 LTR-5’ 377 Lung cancer 15, 291 Lymph 200 Lymph node 130, 133, 197, 198, 266, 300, 336, 344, 347, 395 m5C 184 m6A 184 Macaque model 100, 101, 102, 180, 181, 202, 212, 427, 432, 800, 969, 970 Machine learning 105, 123, 319, 593, 1046 Macrophage 221, 337, 395, 422, 772 MACS 456 Magnetic levitation 330 Magnetic resonance imaging 122, 412, 453, 454, 455, 456, 660 Maintenance therapy 139, 140, 486 Malignancies 285, 286 Malignancy 290, 292 Mannoprotein 706 Marginal structural modeling 649 Mass cytometry 318 Maternal and child health 795 Maternal deaths 765 Maternal perinatal HIV status 793 Mathematical model 99, 318, 349, 525, 538, 764, 912, 1084, Lymphogranuloma venereum 1011 Lymphoid tissue 103, 134, 341, 452 Lymphoma 292 Lysosomal integrity 691 Malawi 754, 1081 Male partners 927

789, 797, 874, 1086 Mozambique 1034 MS-based metabolomics 243 mtDNA 434 mTOR inhibition 131, 301, 400

Integrase inhibitor resistance 74, 533, 535 Integrase resistance testing 143, 526, 535

Keyword Index

Integrase Strand Transfer Inhibitors 34, 143, 439, 442, 443, 451, 472, 495, 504, 511, 523, 530, 535, 547, 550, 553, 669, 670, 672, 674, 675, 680, 744, 745, 746, 747, 906, 985

Mucosal B cells 298 Mucosal barrier 206 Mucosal IgG/IgA 293

Integrase tetrameric form 75 Integration of services 1009 Integration site 339, 341, 348, 805 Integrin 204, 334 Interaction 78 Interactive voice response 1037 Interferon 172

Mucosal immunity 206, 234, 1001 Mucosal immunology 223, 236 Multi-class resistance 544 Multi-morbidity 699 Multi-tablet regimen 511 Multicentric Castleman Disease 17 Multidrug resistance 84, 485, 535, 548, 550, 719 Multimorbidity 697 Multiplicity of infection 168 Multipurpose Prevention 1077 Multivariate normative Comparison 413 Mutation 190, 623 MxB 69 Mycobacterium antigens 718 Myeloid derived suppressor cells 244 Myocardial infarction 31, 664, 665 Nanomedicine 488, 630, 718 National algorithm 782 Natural hosts 210 Natural killer (NK) cells 245, 325323, 324, 357, 365 Near-full-length HIV-1 sequencing 331, 338, 383

Interferon alpha 185 Interferon gamma 715 Interferon inducible transmembrane proteins (IFITM) 172 Interferon stimulate genes 174, 211 Interleukin 6 633 Intervention 955, 1050

Intervention impact 1086 Intima media thickness 635 Intracellular pharmacology 469, 477 Intrauterine device 50 IP-10 196, 335 ISG 167 Isoniazid 77, 79, 80, 82, 719, 723, 724 Jak inhibitor 37 K-Means Clustering 741 K65R 546 K8.1 and ORF73 antigens 269 Kaduna 837

Neisseria gonorrhoeae 925, 1002 Neonatal HIV-1 infection 43, 799 Neonates 827 Network 575, 591, 872, 873

Kaposi sarcoma 19, 20, 270, 271, 272, 274, 275 Kaposi sarcoma-associated diseases 17, 268, 273

CROI 2019 462